- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.35 Å
- Oligo State
- homo-octamer
- Ligands
- 8 x MG: MAGNESIUM ION(Non-covalent)
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
ATP.2: 17 residues within 4Å:- Chain A: W.14, L.22, E.23, E.38, V.41, F.43, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106
- Chain E: M.111, P.112
- Ligands: MG.1
17 PLIP interactions:17 interactions with chain A- Hydrogen bonds: A:T.73, A:G.74, A:G.74, A:S.75, A:G.76, A:G.76, A:K.77, A:T.78, A:S.79, A:Q.106
- Water bridges: A:E.23, A:E.23, A:T.73, A:T.78, A:S.186
- Salt bridges: A:K.77, A:K.77
ATP.5: 14 residues within 4Å:- Chain B: W.14, G.19, F.43, V.53, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106
- Chain H: M.111
- Ligands: MG.4
11 PLIP interactions:11 interactions with chain B- Hydrogen bonds: B:G.74, B:G.74, B:S.75, B:G.76, B:G.76, B:K.77, B:T.78, B:S.79, B:Q.106
- Salt bridges: B:K.77, B:K.77
ATP.8: 17 residues within 4Å:- Chain C: W.14, L.22, E.23, E.38, V.41, F.43, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106
- Chain G: M.111, P.112
- Ligands: MG.7
17 PLIP interactions:17 interactions with chain C- Hydrogen bonds: C:T.73, C:G.74, C:G.74, C:S.75, C:G.76, C:G.76, C:K.77, C:T.78, C:S.79, C:Q.106
- Water bridges: C:E.23, C:E.23, C:T.73, C:T.78, C:S.186
- Salt bridges: C:K.77, C:K.77
ATP.11: 14 residues within 4Å:- Chain D: W.14, G.19, F.43, V.53, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106
- Chain F: M.111
- Ligands: MG.10
11 PLIP interactions:11 interactions with chain D- Hydrogen bonds: D:G.74, D:G.74, D:S.75, D:G.76, D:G.76, D:K.77, D:T.78, D:S.79, D:Q.106
- Salt bridges: D:K.77, D:K.77
ATP.14: 17 residues within 4Å:- Chain C: M.111, P.112
- Chain E: W.14, L.22, E.23, E.38, V.41, F.43, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106
- Ligands: MG.13
17 PLIP interactions:17 interactions with chain E- Hydrogen bonds: E:T.73, E:G.74, E:G.74, E:S.75, E:G.76, E:G.76, E:K.77, E:T.78, E:S.79, E:Q.106
- Water bridges: E:E.23, E:E.23, E:T.73, E:T.78, E:S.186
- Salt bridges: E:K.77, E:K.77
ATP.17: 14 residues within 4Å:- Chain B: M.111
- Chain F: W.14, G.19, F.43, V.53, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106
- Ligands: MG.16
11 PLIP interactions:11 interactions with chain F- Hydrogen bonds: F:G.74, F:G.74, F:S.75, F:G.76, F:G.76, F:K.77, F:T.78, F:S.79, F:Q.106
- Salt bridges: F:K.77, F:K.77
ATP.20: 17 residues within 4Å:- Chain A: M.111, P.112
- Chain G: W.14, L.22, E.23, E.38, V.41, F.43, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106
- Ligands: MG.19
17 PLIP interactions:17 interactions with chain G- Hydrogen bonds: G:T.73, G:G.74, G:G.74, G:S.75, G:G.76, G:G.76, G:K.77, G:T.78, G:S.79, G:Q.106
- Water bridges: G:E.23, G:E.23, G:T.73, G:T.78, G:S.186
- Salt bridges: G:K.77, G:K.77
ATP.23: 14 residues within 4Å:- Chain D: M.111
- Chain H: W.14, G.19, F.43, V.53, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106
- Ligands: MG.22
11 PLIP interactions:11 interactions with chain H- Hydrogen bonds: H:G.74, H:G.74, H:S.75, H:G.76, H:G.76, H:K.77, H:T.78, H:S.79, H:Q.106
- Salt bridges: H:K.77, H:K.77
- 8 x ACY: ACETIC ACID(Non-functional Binders)
ACY.3: 7 residues within 4Å:- Chain A: L.154, G.155, E.156, G.158, V.159, T.160, L.161
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:E.156, A:G.158, A:V.159, A:T.160, A:T.160, A:L.161
ACY.6: 6 residues within 4Å:- Chain B: L.154, G.155, G.158, V.159, T.160, L.161
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:G.155, B:V.159, B:T.160, B:T.160, B:L.161
ACY.9: 7 residues within 4Å:- Chain C: L.154, G.155, E.156, G.158, V.159, T.160, L.161
6 PLIP interactions:6 interactions with chain C- Hydrogen bonds: C:E.156, C:G.158, C:V.159, C:T.160, C:T.160, C:L.161
ACY.12: 6 residues within 4Å:- Chain D: L.154, G.155, G.158, V.159, T.160, L.161
5 PLIP interactions:5 interactions with chain D- Hydrogen bonds: D:G.155, D:V.159, D:T.160, D:T.160, D:L.161
ACY.15: 7 residues within 4Å:- Chain E: L.154, G.155, E.156, G.158, V.159, T.160, L.161
6 PLIP interactions:6 interactions with chain E- Hydrogen bonds: E:E.156, E:G.158, E:V.159, E:T.160, E:T.160, E:L.161
ACY.18: 6 residues within 4Å:- Chain F: L.154, G.155, G.158, V.159, T.160, L.161
5 PLIP interactions:5 interactions with chain F- Hydrogen bonds: F:G.155, F:V.159, F:T.160, F:T.160, F:L.161
ACY.21: 7 residues within 4Å:- Chain G: L.154, G.155, E.156, G.158, V.159, T.160, L.161
6 PLIP interactions:6 interactions with chain G- Hydrogen bonds: G:E.156, G:G.158, G:V.159, G:T.160, G:T.160, G:L.161
ACY.24: 6 residues within 4Å:- Chain H: L.154, G.155, G.158, V.159, T.160, L.161
5 PLIP interactions:5 interactions with chain H- Hydrogen bonds: H:G.155, H:V.159, H:T.160, H:T.160, H:L.161
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lewis, H.A. et al., Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. Embo J. (2004)
- Release Date
- 2003-12-09
- Peptides
- Cystic fibrosis transmembrane conductance regulator: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
DC
CD
DE
CF
DG
CH
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.35 Å
- Oligo State
- homo-octamer
- Ligands
- 8 x MG: MAGNESIUM ION(Non-covalent)
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 8 x ACY: ACETIC ACID(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lewis, H.A. et al., Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. Embo J. (2004)
- Release Date
- 2003-12-09
- Peptides
- Cystic fibrosis transmembrane conductance regulator: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
DC
CD
DE
CF
DG
CH
D